BioPharma testing

Reliable support for all phases of clinical development

Sysmex Inostics specializes in purpose-designed ultra-high sensitivity tests capable of detecting genetic alterations at very low mutant allele frequencies.

Through reliable identification of even the lowest frequency mutations, our OncoBEAM™ and SafeSEQ testing services help ensure the most efficient approach to patient enrollment in clinical trials for targeted therapies.

Our technologies are also ideal to explore novel clinical applications which require ultra-high sensitivity, such as molecular monitoring of minimal residual disease.

SafeSEQ testing

SafeSEQ next-generation sequencing services offer exquisite sensitivity, with reliable detection of 5 mutant molecules in a background of 10,000 wildtype ones (0.05% MAF). We offer expert-designed panels to answer your clinical questions accurately and efficiently.

Learn More →

OncoBEAM™ testing

Detect important mutations from 0.02% to 0.04% allele frequency using BEAMing enhanced digital PCR technology. The OncoBEAM tests are highly clinically validated across numerous disease types to ensure unrivaled depth of information from a simple blood draw.

Learn More →

Rapid Custom SafeSEQ

Choose your own genes and mutations of interest with fast delivery of a custom NGS-based SafeSEQ panel to answer important clinical questions.

Learn More →

Information in accordance with Art. 13 GDPR: https://www.sysmex-inostics.com/data

Germany: Sysmex Inostics GmbH, Falkenried 88, D-20251 Hamburg, Germany. +49 40- 325907-0

United States: Sysmex Inostics, Inc., 1812 Ashland Ave Suite 500, Baltimore, Maryland 21205, USA.   +1-855-BEAM-DNA (232-6362)

Japan: Sysmex Corporation, 1-5-1 Wakinohama-Kaigandori, Chuo-ku, Kobe 651-0073, Japan.   +81 78 265-0500
© Sysmex Inostics